恶性大脑中动脉梗死去骨瓣减压术后颅内压趋势与临床结局
这项回顾性队列研究纳入112例接受去骨瓣减压术的恶性大脑中动脉梗死(MMI)患者,其中66例(58.9%)术后接受有创颅内压(ICP)监测,监测中位时间146.5小时(IQR 72.5-181.8)。根据192小时内ICP值用线性混合模型分为ICP上升组(37例,56.1%)和下降组(29例,43.9%),两组初始ICP和峰值ICP无显著差异,但ICP趋势显著不同(P<0.001)。多因素logistic回归显示,ICP上升组3个月良好结局(改良Rankin量表0-4分)比例显著更低(校正OR 0.11;95%CI 0.01-0.59;P=0.019),ICU死亡率显著更高(校正OR 6.98;95%CI 1.37-54.6;P=0.031)。作者认为连续ICP监测可能有助于识别ICP上升趋势、可能关联不良临床结局的患者。
要点
- 112例MMI去骨瓣减压患者中66例(58.9%)接受有创ICP监测,监测中位146.5小时(IQR 72.5-181.8)。
- 192小时内ICP趋势分为上升组37例(56.1%)与下降组29例(43.9%),两组初始ICP和峰值ICP无显著差异,ICP趋势差异显著(P<0.001)。
- ICP上升组3个月良好结局(mRS 0-4)比例显著低于下降组:校正OR 0.11(95%CI 0.01-0.59;P=0.019)。
- ICP上升组ICU死亡率显著高于下降组:校正OR 6.98(95%CI 1.37-54.6;P=0.031)。
适用人群与场景
- 接受去骨瓣减压术的恶性大脑中动脉梗死(MMI)患者,术后接受有创ICP监测者(66例)。
诊断标准与关键阈值
- 以192小时内ICP值经线性混合模型分为ICP上升组与ICP下降组。
- 3个月良好结局定义为改良Rankin量表(mRS)0-4分。
研究设计与关键结果
- 回顾性队列研究:112例MMI去骨瓣减压患者中66例(58.9%)接受有创ICP监测,监测中位146.5小时(IQR 72.5-181.8)。
- 66例中ICP上升组37例(56.1%),ICP下降组29例(43.9%);两组初始ICP和峰值ICP无显著差异,ICP趋势差异显著(P<0.001)。
- 多因素logistic回归:ICP上升组较下降组3个月良好结局(mRS 0-4)比例显著更低,校正OR 0.11(95%CI 0.01-0.59;P=0.019)。
- 多因素logistic回归:ICP上升组较下降组ICU死亡率显著更高,校正OR 6.98(95%CI 1.37-54.6;P=0.031)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在MMI患者中连续ICP监测可能有助于识别ICP呈上升趋势、可能关联不良临床结局的患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Malignant middle cerebral artery infarction (MMI) is associated with a high incidence of severe disability and mortality. Decompressive hemicraniectomy has become a recognized treatment that can improve the prognosis for patients if performed within a certain time window. Nevertheless, despite this intervention, a mortality rate of approximately 20-40% persists following the surgery. The trends and clinical implications of intracranial pressure (ICP) in these situations remain unclear. We aimed to investigate whether intracranial pressure (ICP) trends are associated with clinical outcomes in patients undergoing decompressive hemicraniectomy for MMI.
METHODS: This retrospective cohort study included consecutive patients with MMI who underwent decompressive craniectomy and received ICP monitoring after surgery. Using a linear mixed model, we categorized the patients into ICP increase and decrease groups based on the ICP values obtained over 192 h. We then compared the proportion of 3-month favorable outcomes (modified Rankin Scale of 0-4) and mortality rates between these groups.
RESULTS: Of 112 MMI patients who underwent decompressive hemicraniectomy, 66 (58.9%) received invasive ICP monitoring. ICP monitoring was performed for a median of 146.5 h (IQR 72.5-181.8). Among the 66 patients, 37 (56.1%) were in the ICP increase group, and 29 (43.9%) were in the ICP decrease group. During the monitoring period, the initial monitored ICP and peak ICP did not significantly differ between the ICP increase and decrease groups. However, the ICP trend was significantly different between the two groups (P < 0.001). In multivariable logistic regression analyses, the ICP increase group had a significantly lower proportion of 3-month favorable outcomes compared to the ICP decrease group (adjusted OR 0.11; 95% CI, 0.01-0.59; P = 0.019), and significantly higher mortality in the intensive care unit (adjusted OR 6.98; 95% CI, 1.37-54.6; P = 0.031).
CONCLUSIONS: In MMI patients, continuous ICP monitoring could be useful for detecting those with an increasing ICP trend that may be associated with unfavorable clinical outcomes.
参考来源
- Jung JW, Kang I, Park J, et al. Intracranial pressure trends and clinical outcomes after decompressive hemicraniectomy in malignant middle cerebral artery infarction. Ann Intensive Care. 2024. PMID: 39592524. doi:10.1186/s13613-024-01412-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。